pubmed-article:16601427 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16601427 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16601427 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:16601427 | lifeskim:mentions | umls-concept:C0546837 | lld:lifeskim |
pubmed-article:16601427 | lifeskim:mentions | umls-concept:C1519429 | lld:lifeskim |
pubmed-article:16601427 | lifeskim:mentions | umls-concept:C0123931 | lld:lifeskim |
pubmed-article:16601427 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
pubmed-article:16601427 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
pubmed-article:16601427 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16601427 | pubmed:dateCreated | 2006-4-7 | lld:pubmed |
pubmed-article:16601427 | pubmed:abstractText | Metastatic esophageal carcinoma is an incurable disease with median survival duration of 6 to 8 months. Based on preclinical data suggesting a dose-dependent synergy between gemcitabine and irinotecan we have conducted a phase II trial in patients with advanced or metastatic esophageal carcinoma. | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:language | eng | lld:pubmed |
pubmed-article:16601427 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16601427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16601427 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16601427 | pubmed:month | Apr | lld:pubmed |
pubmed-article:16601427 | pubmed:issn | 1537-453X | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:AbbruzzeseJam... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:DakhilShaker... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:GandaraDavid... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:AtkinsJames... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:BlankeCharles... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:WilliamsonSte... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:YostKathleen... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:McCoySheryl... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:ParadeloJorge... | lld:pubmed |
pubmed-article:16601427 | pubmed:author | pubmed-author:Southwest... | lld:pubmed |
pubmed-article:16601427 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:16601427 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:16601427 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16601427 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16601427 | pubmed:pagination | 116-22 | lld:pubmed |
pubmed-article:16601427 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:meshHeading | pubmed-meshheading:16601427... | lld:pubmed |
pubmed-article:16601427 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16601427 | pubmed:articleTitle | Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial. | lld:pubmed |
pubmed-article:16601427 | pubmed:affiliation | University of Kansas Medical Center, Kansas City, KS, USA. swilliam@kumc.edu | lld:pubmed |
pubmed-article:16601427 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16601427 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:16601427 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
pubmed-article:16601427 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |